CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD. Wu CY, Cilic A, Pak O, Dartsch RC, et al. Am J Respir Crit Care Med 2023;207:1576-1590.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu CY, Cilic A, Pak O, Dartsch RC, et al. CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD. Am J Respir Crit Care Med 2023;207:1576-1590.
PMID: 37219322